{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:46:39Z","timestamp":1790635599387,"version":"4.1.0"},"reference-count":210,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.bcmd.2024.102860","type":"journal-article","created":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T18:57:56Z","timestamp":1717009076000},"page":"102860","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Diagnosis and management of acquired aplastic anemia in childhood. Guidelines from the Marrow Failure Study Group of the Pediatric Haemato-Oncology Italian Association (AIEOP)"],"prefix":"10.1016","volume":"108","author":[{"given":"A.","family":"Guarina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Farruggia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Saracco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Barone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Onofrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Cesaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Angarano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Barberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bonanomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Corti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Crescenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Dell'Orso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"De Matteo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Giagnuolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.P.","family":"Iori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ladogana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lucarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lupia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Martire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Mastrodicasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Massaccesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Arcuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"Giarratana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Menna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Miano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.D.","family":"Notarangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Palazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Palmisani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Pestarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Pierri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Ramenghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Saettini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Timeus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Verzegnassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Zecca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Fioredda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Dufour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2024.102860_bb0005","series-title":"Hematol Oncol Clin North Am","article-title":"The pathophysiology of acquired aplastic anemia: current concepts revisited","author":"Schoettler","year":"2018"},{"key":"10.1016\/j.bcmd.2024.102860_bb0010","doi-asserted-by":"crossref","unstructured":"N.S. Young, Current concepts in the pathophysiology and treatment of aplastic anemia, in: Hematol. Am Soc Hematol Educ Program 2013, 2013: p. 76 81.","DOI":"10.1182\/asheducation-2013.1.76"},{"key":"10.1016\/j.bcmd.2024.102860_bb0015","doi-asserted-by":"crossref","unstructured":"A. Barone, A. Lucarelli, D. Onofrillo, F. Verzegnassi, S. Bonanomi, S. Cesaro, F. Fioredda, A.P. Iori, S. Ladogana, A. Locasciulli, D. Longoni, M. Lanciotti, A. Macaluso, R. Mandaglio, N. Marra, B. Martire, M. Maruzzi, G. Menna, L.D. Notarangelo, G. Palazzi, M. Pillon, U. Ramenghi, G. Russo, J. Svahn, F. Timeus, F. Tucci, C. Cugno, M. Zecca, P. Farruggia, C. Dufour, P. Saracco, Diagnosis and management of acquired aplastic anemia in childhood. Guidelines from the Marrow Failure Study Group of the Pediatric Haemato-Oncology Italian Association (AIEOP), Blood Cells. Mol. Dis. 55 (2015) 40\u201347. doi:https:\/\/doi.org\/10.1016\/j.bcmd.2015.03.007.","DOI":"10.1016\/j.bcmd.2015.03.007"},{"key":"10.1016\/j.bcmd.2024.102860_bb0020","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/bjh.13853","article-title":"Guidelines for the diagnosis and management of adult aplastic anaemia","volume":"172","author":"Killick","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0025","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2141.2009.07842.x","article-title":"Writing group: British Committee for Standards in Haematology, Guidelines for the diagnosis and management of aplastic anaemia","volume":"147","author":"Marsh","year":"2009","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0030","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3324\/haematol.12855","article-title":"The epidemiology of acquired aplastic anemia","volume":"93","author":"Young","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2024.102860_bb0035","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3324\/haematol.12020","article-title":"the Catalan Group for the Study of Agranulocytosis and Aplastic Anemia, Epidemiology of aplastic anemia: a prospective multicenter study","volume":"93","author":"Montane","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2024.102860_bb0040","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.pcl.2013.08.011","article-title":"Acquired aplastic anemia in children","volume":"60","author":"Hartung","year":"2013","journal-title":"Pediatr. Clin. N. Am."},{"key":"10.1016\/j.bcmd.2024.102860_bb0045","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/jpc.14996","article-title":"Aplastic anaemia: current concepts in diagnosis and management","volume":"56","author":"Furlong","year":"2020","journal-title":"J. Paediatr. Child Health"},{"key":"10.1016\/j.bcmd.2024.102860_bb0050","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/07853890.2014.915579","article-title":"Inherited bone marrow failure syndromes in adolescents and young adults","volume":"46","author":"Wilson","year":"2014","journal-title":"Ann. Med."},{"key":"10.1016\/j.bcmd.2024.102860_bb0055","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJMra1413485","article-title":"Aplastic anemia","volume":"379","author":"Young","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2024.102860_bb0060","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/j.seminhematol.2017.05.001","article-title":"Introduction: genetic syndromes predisposing to myeloid neoplasia","volume":"54","author":"Wlodarski","year":"2017","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0065","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1126\/science.1255904","article-title":"Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4","volume":"345","author":"Kuehn","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.bcmd.2024.102860_bb0070","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s10875-018-0480-4","article-title":"Hematologic manifestations of deficiency of adenosine deaminase 2 (DADA2) and response to tumor necrosis factor inhibition in DADA2-associated bone marrow failure","volume":"38","author":"Michniacki","year":"2018","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0075","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/j.seminhematol.2017.04.004","article-title":"Classical inherited bone marrow failure syndromes with high risk for myelodysplastic syndrome and acute myelogenous leukemia","volume":"54","author":"Savage","year":"2017","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0080","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1182\/asheducation-2011.1.76","article-title":"Diagnosis and management of aplastic anemia","volume":"2011","author":"Guinan","year":"2011","journal-title":"Hematology"},{"key":"10.1016\/j.bcmd.2024.102860_bb0085","first-page":"70","article-title":"Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality","volume":"1","author":"Camitta","year":"1976","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2024.102860_bb0090","first-page":"531","article-title":"Bone marrow transplantation for severe aplastic anemia from donors other than HLA identical siblings: a report of the BMT Working Party","volume":"3","author":"Bacigalupo","year":"1988","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bcmd.2024.102860_bb0095","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11864-017-0511-z","article-title":"Diagnosis and treatment of aplastic anemia","volume":"18","author":"Peslak","year":"2017","journal-title":"Curr. Treat. Options in Oncol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0100","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/bmt.2012.230","article-title":"Diagnosis of acquired aplastic anemia","volume":"48","author":"Rov\u00f3","year":"2013","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bcmd.2024.102860_bb0105","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1182\/blood-2011-08-368308","article-title":"Functional characterization of CD4+ T cells in aplastic anemia","volume":"119","author":"Kordasti","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2024.102860_bb0110","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.3324\/haematol.2009.007815","article-title":"Changes in cytokine profile pre- and post-immunosuppression in acquired aplastic anemia","volume":"94","author":"Dufour","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2024.102860_bb0115","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1182\/blood-2014-01-549527","article-title":"IFN-\u03b3 causes aplastic anemia by altering hematopoietic stem\/progenitor cell composition and disrupting lineage differentiation","volume":"124","author":"Lin","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2024.102860_bb0120","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.3324\/haematol.2015.132530","article-title":"Japan Childhood Aplastic Anemia Study Group, Paroxysmal nocturnal hemoglobinuria and telomere length predicts response to immunosuppressive therapy in pediatric aplastic anemia","volume":"100","author":"Narita","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2024.102860_bb0125","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1182\/blood.V110.11.16.16","article-title":"Constitutional loss-of-function mutations in telomerase are genetic risk factors for acute myeloid leukemia","volume":"110","author":"Calado","year":"2007","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bcmd.2024.102860_bb0130","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/leu.2011.272","article-title":"Short telomeres result in chromosomal instability in hematopoietic cells and precede malignant evolution in human aplastic anemia","volume":"26","author":"Calado","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2024.102860_bb0135","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/bjh.16460","article-title":"Distinctive and common features of moderate aplastic anaemia","volume":"189","author":"Patel","year":"2020","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0140","doi-asserted-by":"crossref","unstructured":"F. Gutierrez-Rodrigues, E. Munger, X. Ma, E.M. Groarke, Y. Tang, B.A. Patel, L.F.B. Catto, D.V. Cl\u00e9, M.R. Niewisch, R.M. Paiva, F. Donaires, A.L. Pinto, G. Borges, B.A. Santana, L.J. McReynolds, N. Giri, B. Altintas, X. Fan, R.N. Shalhoub, C.M. Siwy, C. Diamond, D. Quinones Raffo, K.M. Craft, S. Kajigaya, R.M. Summers, P.P. Liu, L. Cunningham, D.D. Hickstein, C.E. Dunbar, R. Pasquini, M.M. De Oliveira, E.D.R.P. Velloso, B.P. Alter, S.A. Savage, C.M.S. Bonfim, C.O. Wu, R.T. Calado, N.S. Young, Differential diagnosis of bone marrow failure syndromes guided by machine learning, Blood (2022) blood.2022017518. doi:https:\/\/doi.org\/10.1182\/blood.2022017518.","DOI":"10.1182\/blood.2022017518"},{"key":"10.1016\/j.bcmd.2024.102860_bb0145","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1182\/blood-2017-07-794362","article-title":"Clonality in context: hematopoietic clones in their marrow environment","volume":"130","author":"Cooper","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2024.102860_bb0150","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1414799","article-title":"Somatic mutations and clonal hematopoiesis in aplastic anemia","volume":"373","author":"Yoshizato","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2024.102860_bb0155","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa2109965","article-title":"Eltrombopag added to immunosuppression in severe aplastic anemia","volume":"386","author":"Peffault De Latour","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2024.102860_bb0160","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bcmd.2017.03.006","article-title":"A retrospective study of paroxysmal nocturnal hemoglobinuria in pediatric and adolescent patients","volume":"64","author":"Mercuri","year":"2017","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2024.102860_bb0165","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/01.md.0000126763.68170.46","article-title":"Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan","volume":"83","author":"Nishimura","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bcmd.2024.102860_bb0170","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/bjh.17147","article-title":"Paroxysmal nocturnal haemoglobinuria (PNH): novel therapies for an ancient disease","volume":"191","author":"Luzzatto","year":"2020","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0175","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s00277-015-2348-5","article-title":"The role of paroxysmal nocturnal hemoglobinuria clones in response to immunosuppressive therapy of patients with severe aplastic anemia","volume":"94","author":"Zhao","year":"2015","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0180","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1182\/blood.V98.13.3513","article-title":"Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH\/aplastic anemia syndrome","volume":"98","author":"Maciejewski","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2024.102860_bb0185","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1182\/blood-2002-12-3706","article-title":"Polyclonal hematopoiesis maintained in patients with bone marrow failure harboring a minor population of paroxysmal nocturnal hemoglobinuria\u2013type cells","volume":"102","author":"Ishiyama","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2024.102860_bb0190","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1182\/blood-2005-06-2485","article-title":"Minor population of CD55-CD59- blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia","volume":"107","author":"Sugimori","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2024.102860_bb0195","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1182\/blood.V120.21.1269.1269","article-title":"Paroxysmal nocturnal hemoglobinuria clones in children with acquired aplastic anemia: a multicentric study","volume":"120","author":"Timeus","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2024.102860_bb0200","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.3324\/haematol.2016.151852","article-title":"Different clinical characteristics of paroxysmal nocturnal hemoglobinuria in pediatric and adult patients","volume":"102","author":"Urbano-Ispizua","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2024.102860_bb0205","first-page":"93","article-title":"Frequency of paroxysmal nocturnal hemoglobinuria clones by multiparametric flow cytometry in pediatric aplastic anemia patients of Indian ethnic origin, Pediatr. Blood","volume":"63","author":"Sreedharanunni","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.bcmd.2024.102860_bb0210","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2141.2008.07182.x","article-title":"Clinical impact of HLA-DR15, a minor population of paroxysmal nocturnal haemoglobinuria-type cells, and an aplastic anaemia-associated autoantibody in children with acquired aplastic anaemia","volume":"142","author":"Yoshida","year":"2008","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0215","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2141.2010.08219.x","article-title":"Paroxysmal nocturnal haemoglobinuria clones in children with acquired aplastic anaemia: a prospective single centre study","volume":"150","author":"Timeus","year":"2010","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0220","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1182\/asheducation-2009.1.329","article-title":"Clinical approach to marrow failure","volume":"2009","author":"Shimamura","year":"2009","journal-title":"Hematology"},{"key":"10.1016\/j.bcmd.2024.102860_bb0225","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1182\/asheducation-2011.1.84","article-title":"Classification of childhood aplastic anemia and myelodysplastic syndrome","volume":"2011","author":"Niemeyer","year":"2011","journal-title":"Hematology"},{"key":"10.1016\/j.bcmd.2024.102860_bb0230","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3324\/haematol.13755","article-title":"Diagnostic criteria to distinguish hypocellular acute myeloid leukemia from hypocellular myelodysplastic syndromes and aplastic anemia: recommendations for a standardized approach","volume":"94","author":"Bennett","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2024.102860_bb0235","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2024.102860_bb0240","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2024.102860_bb0245","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2559.2011.04156.x","article-title":"Morphological differentiation of severe aplastic anaemia from hypocellular refractory cytopenia of childhood: reproducibility of histopathological diagnostic criteria","volume":"61","author":"Baumann","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.bcmd.2024.102860_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MOP.0b013e3280128ce8","article-title":"Myelodysplastic and myeloproliferative disorders in children","volume":"19","author":"Hasle","year":"2007","journal-title":"Curr. Opin. Pediatr."},{"key":"10.1016\/j.bcmd.2024.102860_bb0255","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2141.2006.06105.x","article-title":"Clinical relevance of cytogenetic abnormalities at diagnosis of acquired aplastic anaemia in adults","volume":"134","author":"Gupta","year":"2006","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0260","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1182\/asheducation-2007.1.29","article-title":"Diagnosis, genetics, and management of inherited bone marrow failure syndromes","volume":"2007","author":"Alter","year":"2007","journal-title":"Hematology"},{"key":"10.1016\/j.bcmd.2024.102860_bb0265","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2017-02-735290","article-title":"Genetic predisposition to hematologic malignancies: management and surveillance","volume":"130","author":"Godley","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2024.102860_bb0270","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1182\/blood.2022016508","article-title":"Genetic testing in severe aplastic anemia is required for optimal hematopoietic cell transplant outcomes","volume":"140","author":"McReynolds","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2024.102860_bb0275","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jaci.2012.11.052","article-title":"Common variable immunodeficiency as the initial presentation of dyskeratosis congenita","volume":"132","author":"Allenspach","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0280","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/bmt.2012.235","article-title":"SAA-WP of the EBMT, Management of acquired aplastic anemia in children","volume":"48","author":"Korthof","year":"2013","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bcmd.2024.102860_bb0285","doi-asserted-by":"crossref","DOI":"10.1101\/mcs.a005769","article-title":"Aplastic anemia in a patient with CVID due to NFKB1 haploinsufficiency","volume":"6","author":"Sklarz","year":"2020","journal-title":"Mol. Case Stud."},{"key":"10.1016\/j.bcmd.2024.102860_bb0290","first-page":"1856","article-title":"Bone marrow transplantation for CVID-like humoral immune deficiency associated with red cell aplasia, Pediatr. Blood","volume":"63","author":"Sayour","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.bcmd.2024.102860_bb0295","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-1172-7-13","article-title":"Nijmegen breakage syndrome (NBS)","volume":"7","author":"Chrzanowska","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bcmd.2024.102860_bb0300","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s10875-020-00930-3","article-title":"Inherited GATA2 deficiency is dominant by haploinsufficiency and displays incomplete clinical penetrance","volume":"41","author":"Oleaga-Quintas","year":"2021","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0305","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1182\/blood-2014-06-580340","article-title":"GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia","volume":"125","author":"Ganapathi","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2024.102860_bb0310","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/ajh.26242","article-title":"Genetic screening of children with marrow failure. The role of primary immunodeficiencies","volume":"96","author":"Miano","year":"2021","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0315","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.754029","article-title":"Case report: deficiency of adenosine deaminase 2 presenting with overlapping features of autoimmune lymphoproliferative syndrome and bone marrow failure","volume":"12","author":"Dell\u2019Orso","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0320","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.revmed.2017.11.006","article-title":"Les multiples facettes du d\u00e9ficit en ADA2, vascularite, maladie auto-inflammatoire et immunod\u00e9ficit: mise au point \u00e0 partir des 135 cas de la litt\u00e9rature","volume":"39","author":"Fayand","year":"2018","journal-title":"Rev. M\u00e9decine Interne"},{"key":"10.1016\/j.bcmd.2024.102860_bb0325","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1038\/s41375-023-02047-z","article-title":"Deciphering treatment patterns in non-severe\/moderate aplastic anemia: an international observational study","volume":"37","author":"Fattizzo","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2024.102860_bb0330","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/bmt.2012.220","article-title":"EBMT Working Party on Aplastic Anemia, Supportive care in severe and very severe aplastic anemia","volume":"48","author":"H\u00f6chsmann","year":"2013","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bcmd.2024.102860_bb0335","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s12185-013-1263-6","article-title":"The progression risk factors of children with transfusion-independent non-severe aplastic anemia","volume":"97","author":"Wang","year":"2013","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0340","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.3324\/haematol.2014.106096","article-title":"Outcome of aplastic anemia in adolescence: a survey of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation","volume":"99","author":"Dufour","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2024.102860_bb0345","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/bjh.13297","article-title":"Outcome of aplastic anaemia in children. A study by the severe aplastic anaemia and paediatric disease working parties of the European group blood and bone marrow transplant","volume":"169","author":"Dufour","year":"2015","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0350","doi-asserted-by":"crossref","first-page":"e677","DOI":"10.1097\/MPH.0000000000001981","article-title":"Allogeneic hematopoietic stem cell transplant offer good outcomes in pediatric aplastic anemia: experience from developing world","volume":"43","author":"Sachdev","year":"2021","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0355","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1182\/blood-2007-03-081596","article-title":"Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia","volume":"110","author":"Schrezenmeier","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2024.102860_bb0360","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1182\/blood-2016-08-693481","article-title":"How I treat acquired aplastic anemia","volume":"129","author":"Bacigalupo","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2024.102860_bb0365","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3324\/haematol.2011.054841","volume":"97","author":"Bacigalupo","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2024.102860_bb0370","doi-asserted-by":"crossref","first-page":"710","DOI":"10.3324\/haematol.2011.050096","article-title":"Long-term follow up after allogeneic stem cell transplantation in patients with severe aplastic anemia after cyclophosphamide plus antithymocyte globulin conditioning","volume":"97","author":"Konopacki","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2024.102860_bb0375","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1182\/blood.V100.3.799","article-title":"Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program","volume":"100","author":"Kojima","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2024.102860_bb0380","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1182\/blood.V70.1.116.116","article-title":"Second marrow transplants in patients with aplastic anemia rejecting the first graft: use of a conditioning regimen including cyclophosphamide and antithymocyte globulin","volume":"70","author":"Storb","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2024.102860_bb0385","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1182\/blood.V84.3.941.941","article-title":"Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia","volume":"84","author":"Storb","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2024.102860_bb0390","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1053\/bbmt.2001.v7.pm11215697","article-title":"Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers","volume":"7","author":"Storb","year":"2001","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.bcmd.2024.102860_bb0395","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1182\/blood-2006-10-052308","article-title":"Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens","volume":"109","author":"Champlin","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2024.102860_bb0400","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/ajh.25314","volume":"94","author":"Samarasinghe","year":"2019","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0405","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1182\/blood.V43.2.157.157","article-title":"Allogeneic marrow grafting for treatment of aplastic anemia","volume":"43","author":"Storb","year":"1974","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2024.102860_bb0410","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1182\/blood.V68.1.119.119","article-title":"Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease","volume":"68","author":"Storb","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2024.102860_bb0415","first-page":"1690","volume":"96","author":"Locatelli","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2024.102860_bb0420","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/bmt.2013.115","volume":"49","author":"Marsh","year":"2014","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bcmd.2024.102860_bb0425","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1182\/blood-2010-12-327536","article-title":"Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia","volume":"118","author":"Marsh","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2024.102860_bb0430","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/j.bbmt.2015.05.023","article-title":"Tacrolimus versus cyclosporine after hematopoietic cell transplantation for acquired aplastic anemia","volume":"21","author":"Inamoto","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.bcmd.2024.102860_bb0435","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3324\/haematol.2014.115345","article-title":"Aplastic Anemia Working Party of the European Group for Blood Marrow Transplantation (WPSAA-EBMT), Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis","volume":"100","author":"Bacigalupo","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2024.102860_bb0440","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.26354","article-title":"Upfront unrelated donor hematopoietic stem cell transplantation in patients with idiopathic aplastic anemia: a retrospective study of the Severe Aplastic Anemia Working Party of European Bone Marrow Transplantation","volume":"97","author":"Petit","year":"2022","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0445","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1182\/blood-2014-05-574889","article-title":"Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome","volume":"124","author":"Kulasekararaj","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2024.102860_bb0450","doi-asserted-by":"crossref","unstructured":"C. Dufour, P. Veys, E. Carraro, N. Bhatnagar, M. Pillon, R. Wynn, B. Gibson, A.J. Vora, C.G. Steward, A.M. Ewins, R.E. Hough, J. De La Fuente, M. Velangi, P.J. Amrolia, R. Skinner, A. Bacigalupo, A.M. Risitano, G. Socie, R. Peffault De Latour, J. Passweg, A. Rovo, A. Tichelli, H. Schrezenmeier, B. Hochsmann, P. Bader, A. Van Biezen, M.D. Aljurf, A. Kulasekararaj, J.C. Marsh, S. Samarasinghe, Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT, Br. J. Haematol. 171 (2015) 585\u2013594. doi:https:\/\/doi.org\/10.1111\/bjh.13614.","DOI":"10.1111\/bjh.13614"},{"key":"10.1016\/j.bcmd.2024.102860_bb0455","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/bmt.2016.223","article-title":"Immunosuppressive therapy versus alternative donor hematopoietic stem cell transplantation for children with severe aplastic anemia who lack an HLA-matched familial donor","volume":"52","author":"Choi","year":"2017","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bcmd.2024.102860_bb0460","doi-asserted-by":"crossref","unstructured":"L.G. Darrigo Jr, V. Colturato, M.P. De Souza, G. Loth, R. Calixto, A. Seber, V.G. Zecchin, L. Esteves Daudt, R.B. Tavares, L. Arcuri, A.V. De Macedo, A.K. Vieira, C. Kuwahara, L. Ribeiro, J.F. Fernandes, M.E. Flowers, R. Pasquini, C. Bonfim, Allogeneic bone marrow transplants for pediatric severe aplastic anemia: real-world data comparing matched related and unrelated donors in a developing country. Retrospective study on behalf of the Pediatric Hematopoietic Stem Cell Transplant Working Group of the Brazilian Bone Marrow Transplantation Society (SBTMO) and the Brazil-Seattle Consortium (Gedeco), Pediatr. Transplant. 23 (2019) e13552. doi:https:\/\/doi.org\/10.1111\/petr.13552.","DOI":"10.1111\/petr.13552"},{"key":"10.1016\/j.bcmd.2024.102860_bb0465","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28444","volume":"67","author":"Pulsipher","year":"2020","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.bcmd.2024.102860_bb0470","doi-asserted-by":"crossref","DOI":"10.1182\/hem.V20.6.202368","article-title":"Two national clinical trials poised to expand the role of bone marrow transplant in newly diagnosed severe aplastic anemia","volume":"20","author":"Muffly","year":"2023","journal-title":"The Hematologist"},{"key":"10.1016\/j.bcmd.2024.102860_bb0475","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/sj.bmt.1705165","volume":"36","author":"Bacigalupo","year":"2005","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bcmd.2024.102860_bb0480","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1182\/blood-2006-03-005041","article-title":"Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy","volume":"108","author":"Deeg","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2024.102860_bb0485","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1053\/bbmt.2001.v7.pm11349807","article-title":"Marrow transplants from unrelated donors for patients with aplastic anemia: minimum effective dose of total body irradiation","volume":"7","author":"Deeg","year":"2001","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.bcmd.2024.102860_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100772","article-title":"Allogeneic hematopoietic stem cell transplantation in aplastic anemia: current indications and transplant strategies","volume":"47","author":"Iftikhar","year":"2021","journal-title":"Blood Rev."},{"key":"10.1016\/j.bcmd.2024.102860_bb0495","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1016\/j.bbmt.2020.06.027","article-title":"Fludarabine, Campath, and low-dose cyclophosphamide (FCClow) with or without TBI conditioning results in excellent transplant outcomes in children with severe aplastic anemia","volume":"26","author":"Shah","year":"2020","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.bcmd.2024.102860_bb0500","doi-asserted-by":"crossref","first-page":"e367","DOI":"10.1016\/S2352-3026(15)00147-7","article-title":"Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1\u20132 dose de-escalation study","volume":"2","author":"Anderlini","year":"2015","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0505","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3324\/haematol.2009.018267","article-title":"Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA working party","volume":"95","author":"Bacigalupo","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2024.102860_bb0510","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12865-020-0340-x","article-title":"Allo-HSCT compared with immunosuppressive therapy for acquired aplastic anemia: a system review and meta-analysis","volume":"21","author":"Zhu","year":"2020","journal-title":"BMC Immunol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0515","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1056\/NEJMoa1103975","article-title":"Horse versus rabbit antithymocyte globulin in acquired aplastic anemia","volume":"365","author":"Scheinberg","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2024.102860_bb0520","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s12185-017-2179-3","article-title":"Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemia","volume":"105","author":"Hayakawa","year":"2017","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0525","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-2141.2008.07450.x","article-title":"Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia","volume":"144","author":"Scheinberg","year":"2009","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0530","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1182\/bloodadvances.2018020248","article-title":"Activity of eltrombopag in severe aplastic anemia","volume":"2","author":"Scheinberg","year":"2018","journal-title":"Blood Adv."},{"key":"10.1016\/j.bcmd.2024.102860_bb0535","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1200931","article-title":"Eltrombopag and improved hematopoiesis in refractory aplastic anemia","volume":"367","author":"Olnes","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2024.102860_bb0540","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1182\/blood-2013-10-534743","article-title":"Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug","volume":"123","author":"Desmond","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2024.102860_bb0545","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJMoa1613878","article-title":"Eltrombopag added to standard immunosuppression for aplastic anemia","volume":"376","author":"Townsley","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2024.102860_bb0550","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1182\/blood.2019000478","article-title":"Treatment optimization and genomic outcomes in refractory severe aplastic anemia treated with eltrombopag","volume":"133","author":"Winkler","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2024.102860_bb0555","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3324\/haematol.2017.176339","article-title":"Nationwide survey on the use of eltrombopag in patients with severe aplastic anemia: a report on behalf of the French Reference Center for Aplastic Anemia","volume":"103","author":"Lengline","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2024.102860_bb0560","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/bjh.17232","article-title":"Eltrombopag added to immunosuppression for children with treatment-na\u00efve severe aplastic anaemia","volume":"192","author":"Groarke","year":"2021","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0565","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/08880018.2021.1895924","article-title":"Efficacy and safety of immunosuppressive therapy with or without eltrombopag in pediatric patients with acquired aplastic anemia: a Chinese retrospective study","volume":"38","author":"Fang","year":"2021","journal-title":"Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0570","first-page":"1","article-title":"Efficacy and safety of immunosuppressive therapy with or without eltrombopag in pediatric patients with acquired aplastic anemia: a Chinese retrospective study","volume":"16","author":"Fang","year":"2021","journal-title":"Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0575","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1080\/08880018.2021.1900475","article-title":"Efficacy and safety of eltrombopag in the first-line therapy of severe aplastic anemia in children","volume":"38","author":"Jie","year":"2021","journal-title":"Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0580","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29066","article-title":"Eltrombopag in children with severe aplastic anemia","volume":"68","author":"Lesmana","year":"2021","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.bcmd.2024.102860_bb0585","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1182\/bloodadvances.2021006716","article-title":"Efficacy of combined immunosuppression with or without eltrombopag in children with newly diagnosed aplastic anemia","volume":"7","author":"Goronkova","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.bcmd.2024.102860_bb0590","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1053\/j.seminhematol.2016.01.002","article-title":"Alternative donor transplants for severe aplastic anemia: current experience","volume":"53","author":"Bacigalupo","year":"2016","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0595","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.1097\/MJT.0000000000000366","article-title":"Comparison of haploidentical hematopoietic stem cell transplantation and immunosuppressive therapy for the treatment of acquired severe aplastic anemia in pediatric patients","volume":"24","author":"Zhang","year":"2017","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.bcmd.2024.102860_bb0600","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood-2014-03-563817","article-title":"HLA-haploidentical stem cell transplantation after removal of \u03b1\u03b2+ T and B cells in children with nonmalignant disorders","volume":"124","author":"Bertaina","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2024.102860_bb0605","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1399-3046.2008.01002.x","article-title":"Cotransplantation of haploidentical mesenchymal stem cells to enhance engraftment of hematopoietic stem cells and to reduce the risk of graft failure in two children with severe aplastic anemia","volume":"13","author":"Fang","year":"2009","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.bcmd.2024.102860_bb0610","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.bbmt.2013.01.023","article-title":"Excellent outcome of haploidentical hematopoietic stem cell transplantation in children and adolescents with acquired severe aplastic anemia","volume":"19","author":"Im","year":"2013","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.bcmd.2024.102860_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2018.05.015","article-title":"Unmanipulated haploidentical hematopoietic stem cell transplantation achieved outcomes comparable with matched unrelated donor transplantation in young acquired severe aplastic anemia","volume":"24","author":"Lu","year":"2018","journal-title":"Biol Blood Marrow Transpl."},{"key":"10.1016\/j.bcmd.2024.102860_bb0620","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ajh.21693","article-title":"Successful unmanipulated stem cell transplantation from HLA-haploidentical 3-loci-mismatched parents in two children with severe aplastic anemia not responding to immunosuppressive therapy","volume":"85","author":"Wang","year":"2010","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0625","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/bmt.2016.281","article-title":"Haploidentical transplantation for pediatric patients with acquired severe aplastic anemia","volume":"52","author":"Xu","year":"2017","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bcmd.2024.102860_bb0630","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.bbmt.2019.01.017","article-title":"Comparison of outcomes of frontline immunosuppressive therapy and frontline haploidentical hematopoietic stem cell transplantation for children with severe aplastic anemia who lack an HLA-matched sibling donor","volume":"25","author":"Yang","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.bcmd.2024.102860_bb0635","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.bbmt.2016.12.628","article-title":"Alternative donor transplantation with high-dose post-transplantation cyclophosphamide for refractory severe aplastic anemia","volume":"23","author":"DeZern","year":"2017","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.bcmd.2024.102860_bb0640","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.bbmt.2014.06.028","article-title":"Nonmyeloablative peripheral blood haploidentical stem cell transplantation for refractory severe aplastic anemia","volume":"20","author":"Clay","year":"2014","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.bcmd.2024.102860_bb0645","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/bmt.2010.213","article-title":"Post-transplantation cyclophosphamide for GVHD prophylaxis in severe aplastic anemia","volume":"46","author":"DeZern","year":"2011","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bcmd.2024.102860_bb0650","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1182\/bloodadvances.2020001729","article-title":"Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide","volume":"4","author":"DeZern","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.bcmd.2024.102860_bb0655","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/bmt.2015.20","article-title":"Haploidentical BMT and post-transplant Cy for severe aplastic anemia: a multicenter retrospective study","volume":"50","author":"Esteves","year":"2015","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bcmd.2024.102860_bb0660","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/bmt.2016.284","article-title":"Successful haploidentical stem cell transplantation for three adults with primary hemophagocytic lymphohistiocytosis","volume":"52","author":"Li","year":"2017","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bcmd.2024.102860_bb0665","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/s41409-021-01227-8","article-title":"European Society for Blood and Marrow Transplantation (EBMT), Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years","volume":"56","author":"Passweg","year":"2021","journal-title":"Bone Marrow Transplant."},{"issue":"12","key":"10.1016\/j.bcmd.2024.102860_bb0670","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.3324\/haematol.2022.280758","article-title":"Comparable long-term outcomes between upfront haploidentical and identical sibling donor transplant in aplastic anemia: a national registry-based study","volume":"107","author":"Xu","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2024.102860_bb0675","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2023020435","article-title":"Alternative donor BMT with post-transplant cyclophosphamide as initial therapy for acquired severe aplastic anemia","author":"DeZern","year":"2023","journal-title":"Blood J."},{"key":"10.1016\/j.bcmd.2024.102860_bb0680","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1046\/j.1365-2141.1999.01693.x","article-title":"Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy","volume":"107","author":"Di Bona","year":"1999","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0685","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1038\/s41409-019-0736-5","article-title":"Unrelated cord blood transplantation for severe aplastic anemia using intensified immunoablative conditioning regimen leading to high engraftment and survival","volume":"55","author":"Du","year":"2020","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bcmd.2024.102860_bb0690","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1182\/blood-2018-01-829630","article-title":"Unrelated cord blood transplantation in patients with idiopathic refractory severe aplastic anemia: a nationwide phase 2 study","volume":"132","author":"Peffault De Latour","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2024.102860_bb0695","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1046\/j.1365-2141.1998.00578.x","article-title":"Repeated treatment with horse antilymphocyte globulin for severe aplastic anaemia","volume":"100","author":"Tichelli","year":"1998","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0700","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1365-2141.2006.06085.x","article-title":"Treatment of severe aplastic anaemia with combined immunosuppression: anti-thymocyte globulin, ciclosporin and mycophenolate mofetil","volume":"133","author":"Scheinberg","year":"2006","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0705","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1365-2141.2005.05406.x","article-title":"A third course of anti-thymocyte globulin in aplastic anaemia is only beneficial in previous responders","volume":"129","author":"Gupta","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0710","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1182\/blood-2007-08-099168","article-title":"Prospective multicenter trial comparing repeated immunosuppressive therapy with stem-cell transplantation from an alternative donor as second-line treatment for children with severe and very severe aplastic anemia","volume":"111","author":"Kosaka","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2024.102860_bb0715","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1080\/17474086.2019.1645003","article-title":"Management of aplastic anemia after failure of frontline immunosuppression","volume":"12","author":"Pierri","year":"2019","journal-title":"Expert Rev. Hematol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0720","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev.immunol.14.1.483","article-title":"Immunopharmacology of rapamycin","volume":"14","author":"Abraham","year":"1996","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0725","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000020669","article-title":"Successful sirolimus therapy of an aplastic anemia patient with chronic kidney disease: a case report","volume":"99","author":"Niu","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"10.1016\/j.bcmd.2024.102860_bb0730","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/MPH.0000000000000647","article-title":"High dose cyclophosphamide is effective therapy for pediatric severe aplastic anemia","volume":"38","author":"Gamper","year":"2016","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0735","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1182\/blood-2014-05-573642","article-title":"Moderate-dose cyclophosphamide for severe aplastic anemia has significant toxicity and does not prevent relapse and clonal evolution","volume":"124","author":"Scheinberg","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2024.102860_bb0740","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/10245332.2018.1435045","article-title":"Danazol increases T regulatory cells in patients with aplastic anemia","volume":"23","author":"Khurana","year":"2018","journal-title":"Hematology"},{"key":"10.1016\/j.bcmd.2024.102860_bb0745","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1056\/NEJMc1607752","article-title":"Danazol treatment for telomere diseases","volume":"375","author":"Townsley","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2024.102860_bb0750","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.3324\/haematol.2015.129239","article-title":"Therapeutic effect of androgen therapy in a mouse model of aplastic anemia produced by short telomeres","volume":"100","author":"Bar","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2024.102860_bb0755","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/bjh.16997","article-title":"Androgen derivatives improve blood counts and elongate telomere length in adult cryptic dyskeratosis congenita","volume":"193","author":"Kirschner","year":"2021","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0760","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1182\/blood-2008-09-178871","article-title":"Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells","volume":"114","author":"Calado","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2024.102860_bb0765","doi-asserted-by":"crossref","unstructured":"A.M. Risitano, C. Selleri, B. Serio, G.F. Torelli, A. Kulagin, S. Maury, J. Halter, V. Gupta, A. Bacigalupo, G. Soci\u00e8, A. Tichelli, H. Schrezenmeier, J. Marsh, J. Passweg, B. Rotoli, Working Party Severe Aplastic Anaemia (WPSAA) of the European Group for Blood and Marrow Transplantation (EBMT). Alemtuzumab is safe and effective as immunosuppressive treatment for aplastic anaemia and single lineage marrow failure: a pilot study and a survey from the EBMT WPSAA, Br J Haematol Mar;148(5):791 6 (2010).","DOI":"10.1111\/j.1365-2141.2009.08027.x"},{"key":"10.1016\/j.bcmd.2024.102860_bb0770","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/bmt.2012.245","article-title":"Alternative immunosuppression in patients failing immunosuppression with ATG who are not transplant candidates: Campath (Alemtuzumab)","volume":"48","author":"Risitano","year":"2013","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bcmd.2024.102860_bb0775","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.3324\/haematol.2018.212845","article-title":"Thrombopoietin receptor agonists: ten years later","volume":"104","author":"Ghanima","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2024.102860_bb0780","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/s41375-020-0950-6","article-title":"High-dose romiplostim accelerates hematologic recovery in patients with aplastic anemia refractory to eltrombopag","volume":"35","author":"Hosokawa","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2024.102860_bb0785","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1182\/blood-2018-99-112478","article-title":"Efficacy and safety of romiplostim in patients with acquired aplastic anemia ineligible or refractory to immunosuppressive therapy: interim analysis of phase 2\/3 clinical trial","volume":"132","author":"Tomiyama","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2024.102860_bb0790","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s12185-021-03165-z","article-title":"Rapid blood cell recovery with immunosuppressive therapy combined with romiplostim in a patient with very severe hepatitis-associated aplastic anemia who underwent liver transplantation","volume":"114","author":"Yoshinari","year":"2021","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0795","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.1097\/MPH.0000000000001810","article-title":"Up-front treatment with romiplostim in children with acquired bone marrow failure: a single institutional pediatric case series","volume":"43","author":"Al-Huniti","year":"2021","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0800","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/bmt.2009.296","article-title":"Aplastic Anaemia Working Party of the European Group for Blood and Marrow Transplantation (WPSAA, EBMT), Survival of patients with documented autologous recovery after SCT for severe aplastic anemia: a study by the WPSAA of the EBMT","volume":"45","author":"Piccin","year":"2010","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bcmd.2024.102860_bb0805","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/bjh.13650","volume":"171","author":"Cesaro","year":"2015","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0810","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/bmt.2015.153","article-title":"Japanese Hematopoietic Cell Transplantation Registry, Second allogeneic hematopoietic stem cell transplantation in children with severe aplastic anemia","volume":"50","author":"Kudo","year":"2015","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bcmd.2024.102860_bb0815","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1038\/bmt.2009.374","article-title":"HLA-matched sibling transplantation with BM and CD34+-purified PBSCs in adult patients with high-risk severe aplastic anemia to overcome graft rejection without an increase in GVHD","volume":"45","author":"Cho","year":"2010","journal-title":"Bone Marrow Transplant."},{"issue":"Suppl. 5","key":"10.1016\/j.bcmd.2024.102860_bb0820","first-page":"S41","article-title":"Peripheral blood stem cell collection from G-CSF-stimulated unrelated donors for second transplant","volume":"22","author":"Dini","year":"1998","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bcmd.2024.102860_bb0825","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.3324\/haematol.12798","article-title":"Second donation of hematopoietic stem cells from unrelated donors for patients with relapse or graft failure after allogeneic transplantation","volume":"93","author":"Platzbecker","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2024.102860_bb0830","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.3324\/haematol.2018.206540","article-title":"Immunosuppressive therapy for pediatric aplastic anemia: a North American Pediatric Aplastic Anemia Consortium study","volume":"104","author":"Rogers","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2024.102860_bb0835","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1111\/j.1537-2995.2009.02273.x","article-title":"ABO-identical versus nonidentical platelet transfusion: a systematic review","volume":"49","author":"Shehata","year":"2009","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.bcmd.2024.102860_bb0840","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.3324\/haematol.2009.010231","article-title":"Granulocyte transfusions in severe aplastic anemia: an eleven-year experience","volume":"94","author":"Quillen","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2024.102860_bb0845","article-title":"Granulocyte transfusion combined with granulocyte colony stimulating factor in severe infection patients with severe aplastic anemia: a single center experience from China","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bcmd.2024.102860_bb0850","first-page":"181","article-title":"Is white blood cell reduction equivalent to antibody screening in preventing transmission of cytomegalovirus by transfusion? A review of the literature and meta-analysis, Transfus","volume":"19","author":"Vamvakas","year":"2005","journal-title":"Med. Rev."},{"key":"10.1016\/j.bcmd.2024.102860_bb0855","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1365-2141.1997.812721.x","article-title":"Pilot study of HLA alloimmunization after transfusion with pre-storage leucodepleted blood products in aplastic anaemia","volume":"97","author":"Killick","year":"1997","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0860","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2141.2010.08444.x","article-title":"Guidelines on the use of irradiated blood components prepared by the British Committee for Standards in Haematology blood transfusion task force","volume":"152","author":"Treleaven","year":"2011","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0865","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1182\/hematology.2019000036","article-title":"Iron overload in transfusion-dependent patients","volume":"2019","author":"Coates","year":"2019","journal-title":"Hematology"},{"key":"10.1016\/j.bcmd.2024.102860_bb0870","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1182\/asheducation-2010.1.36","article-title":"Aplastic anemia: first-line treatment by immunosuppression and sibling marrow transplantation","volume":"2010","author":"Passweg","year":"2010","journal-title":"Hematology"},{"key":"10.1016\/j.bcmd.2024.102860_bb0875","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3324\/haematol.2009.017244","article-title":"Iron overload in hematologic malignancies and outcome of allogeneic hematopoietic stem cell transplantation","volume":"95","author":"Koreth","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2024.102860_bb0880","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1182\/blood-2006-10-054924","article-title":"Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation","volume":"109","author":"Armand","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2024.102860_bb0885","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/bmt.2008.262","article-title":"Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation","volume":"42","author":"Pullarkat","year":"2008","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bcmd.2024.102860_bb0890","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1080\/10428190903144659","article-title":"Iron overload, hematopoietic cell transplantation, and graft- versus -host disease","volume":"50","author":"Joachim Deeg","year":"2009","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.bcmd.2024.102860_bb0895","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1111\/trf.12507","volume":"54","author":"Cheong","year":"2014","journal-title":"Transfusion (Paris)"},{"issue":"1","key":"10.1016\/j.bcmd.2024.102860_bb0900","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/16078454.2018.1557860","article-title":"Long term safety and efficacy of deferasirox in patients with myelodysplastic syndrome, aplastic anemia and other rare anemia in Taiwan","volume":"24","author":"Ko","year":"2019","journal-title":"Hematology"},{"key":"10.1016\/j.bcmd.2024.102860_bb0905","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000479422","article-title":"Observational monitoring of patients with aplastic anemia and low\/intermediate-1 risk of myelodysplastic syndromes complicated with iron overload","volume":"138","author":"Du","year":"2017","journal-title":"Acta Haematol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0910","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12185-008-0117-0","article-title":"Iron chelation therapy in the myelodysplastic syndromes and aplastic anemia: a review of experience in South Korea","volume":"88","author":"Lee","year":"2008","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0915","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.blre.2018.04.004","article-title":"Iron toxicity \u2013 its effect on the bone marrow","volume":"32","author":"Isidori","year":"2018","journal-title":"Blood Rev."},{"key":"10.1016\/j.bcmd.2024.102860_bb0920","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1182\/blood-2010-01-261289","article-title":"Porter, on behalf of the EPIC study investigators, Iron chelation therapy with deferasirox in patients with aplastic anemia: a subgroup analysis of 116 patients from the EPIC trial","volume":"116","author":"Lee","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2024.102860_bb0925","first-page":"152","article-title":"Australian Aplastic Anaemia Registry Steering Committee, Revisiting acquired aplastic anaemia: current concepts in diagnosis and management, Intern","volume":"49","author":"Clucas","year":"2019","journal-title":"Med. J."},{"key":"10.1016\/j.bcmd.2024.102860_bb0930","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1182\/blood-2010-08-304071","article-title":"A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation","volume":"117","author":"Tichelli","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2024.102860_bb0935","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3324\/haematol.2019.222562","volume":"105","author":"Tichelli","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2024.102860_bb0945","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1182\/blood-2006-11-050526","article-title":"Treatment of severe aplastic anemia with antithymocyte globulin and cyclosporin A with or without G-CSF in adults: a multicenter randomized study in Japan","volume":"110","author":"Teramura","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2024.102860_bb0950","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.4049\/jimmunol.1500861","article-title":"G-CSF and GM-CSF in neutropenia","volume":"195","author":"Mehta","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0955","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1007\/s00277-017-3086-7","article-title":"Predictors of early mortality after rabbit antithymocyte globulin as first-line treatment in severe aplastic anemia","volume":"96","author":"Atta","year":"2017","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0960","first-page":"473","article-title":"Alternative donor transplants for severe aplastic anemia","volume":"2018","author":"Bacigalupo","year":"2018","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.bcmd.2024.102860_bb0965","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1600-0609.2012.01770.x","article-title":"Epidemiology of infections in children with acquired aplastic anaemia: a retrospective multicenter study in Italy","volume":"88","author":"Quarello","year":"2012","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0970","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1016\/S1470-2045(14)70017-8","article-title":"Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation","volume":"15","author":"Groll","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bcmd.2024.102860_bb0975","unstructured":"D. Averbuch, C. Cordonnier, D.M. Livermore, M. Mikulska, C. Orasch, C. Viscoli, I.C. Gyssens, W.V. Kern, G. Klyasova, O. Marchetti, D. Engelhard, M. Akova, ECIL4, a joint venture of EBMT, EORTC, ICHS, ESGICH\/ESCMID and ELN. Targeted therapy against multi resistant bacteria in leukemic and hematopoietic stem cell transplant recipients, in: Guidel. 4th Eur. Conf. Infect. Leuk., n.d."},{"key":"10.1016\/j.bcmd.2024.102860_bb0980","unstructured":"A. Verlinden, M. Mikulska, N.S. Knelange, D. Averbuch, J. Styczynski, Infectious Diseases Working Party (IDWP) of the European Group for Blood and Marrow Transplantation Group (EBMT). Current antimicrobial practice in febrile neutropenia across Europe and Asia: the EBMT Infectious Disease Working Party survey, (n.d.)."},{"key":"10.1016\/j.bcmd.2024.102860_bb0985","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/707691","article-title":"Guidelines on vaccinations in paediatric haematology and oncology patients","volume":"2014","author":"Cesaro","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.bcmd.2024.102860_bb0990","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1186\/s13023-023-02993-y","article-title":"Experience of life quality from patients with aplastic anemia: a descriptive qualitative study","volume":"18","author":"Liu","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bcmd.2024.102860_bb0995","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s00277-019-03681-3","article-title":"Design and development of a disease-specific quality of life tool for patients with aplastic anaemia and\/or paroxysmal nocturnal haemoglobinuria (QLQ-AA\/PNH)\u2014a report on phase III","volume":"98","author":"Niedeggen","year":"2019","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.bcmd.2024.102860_bb1000","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00277-016-2867-8","article-title":"Development of a disease-specific quality of life questionnaire for patients with aplastic anemia and\/or paroxysmal nocturnal hemoglobinuria (QLQ-AA\/PNH)\u2014report on phases I and II","volume":"96","author":"Groth","year":"2017","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.bcmd.2024.102860_bb1005","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.3109\/14767058.2015.1037733","article-title":"Aplastic anemia associated with pregnancy: maternal and fetal complications","volume":"29","author":"Bo","year":"2016","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.bcmd.2024.102860_bb1010","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2147\/IJWH.S149683","article-title":"Aplastic anemia during pregnancy: a review of obstetric and anesthetic considerations","volume":"10","author":"Riveros-Perez","year":"2018","journal-title":"Int. J. Women\u2019s Health"},{"key":"10.1016\/j.bcmd.2024.102860_bb1015","doi-asserted-by":"crossref","first-page":"164","DOI":"10.7326\/0003-4819-137-3-200208060-00008","article-title":"Outcome of pregnancy and disease course among women with aplastic anemia treated with immunosuppression","volume":"137","author":"Tichelli","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bcmd.2024.102860_bb1020","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.tjog.2017.08.010","article-title":"Longterm outcome of pregnancy complicating with severe aplastic anemia under supportive care","volume":"56","author":"Chen","year":"2017","journal-title":"Taiwan. J. Obstet. Gynecol."},{"key":"10.1016\/j.bcmd.2024.102860_bb1025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103066","article-title":"Association of severe thrombocytopenia and poor prognosis in pregnancies with aplastic anemia","volume":"9","author":"Shin","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bcmd.2024.102860_bb1030","first-page":"329","article-title":"Pregnancy after bone marrow transplantation for severe aplastic anemia","volume":"2","author":"Schmidt","year":"1987","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bcmd.2024.102860_bb1035","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1182\/blood.2020007594","article-title":"Use of thrombopoietin receptor agonists for immune thrombocytopenia in pregnancy: results from a multicenter study","volume":"136","author":"Michel","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2024.102860_bb1040","doi-asserted-by":"crossref","unstructured":"M.G. Piccioni, C. Capone, F. Vena, V. Del Negro, M.C. Schiavi, V. D'Ambrosio, A. Giancotti, M.P. Smacchia, R. Brunelli, Use of deferoxamine (DFO) in transfusion-dependent \u03b2-thalassemia during pregnancy: a retrospective study, Taiwan. J. Obstet. Gynecol. 59 (2020) 120\u2013122. doi:https:\/\/doi.org\/10.1016\/j.tjog.2019.11.018.","DOI":"10.1016\/j.tjog.2019.11.018"},{"key":"10.1016\/j.bcmd.2024.102860_bb1045","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s12185-016-1945-y","article-title":"Iron chelation therapy of transfusion-dependent \u03b2-thalassemia during pregnancy in the era of novel drugs: is deferasirox toxic?","volume":"103","author":"Diamantidis","year":"2016","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.bcmd.2024.102860_bb1050","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/bmt.2011.78","article-title":"Fertility after allogeneic haematopoietic stem cell transplantation in childhood and adolescence","volume":"47","author":"Borgmann-Staudt","year":"2012","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bcmd.2024.102860_bb1055","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00432-014-1781-5","article-title":"Dynamics of fertility impairment and recovery after allogeneic haematopoietic stem cell transplantation in childhood and adolescence: results from a longitudinal study","volume":"141","author":"Pfitzer","year":"2015","journal-title":"J. Cancer Res. Clin. Oncol."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107997962400038X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107997962400038X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T19:17:33Z","timestamp":1721416653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107997962400038X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":210,"alternative-id":["S107997962400038X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2024.102860","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and management of acquired aplastic anemia in childhood. Guidelines from the Marrow Failure Study Group of the Pediatric Haemato-Oncology Italian Association (AIEOP)","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2024.102860","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102860"}}